English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Hepatitis B virus (HBV) is a global scourge, affecting over two billion people worldwide, with 350 million active infections (Franco et al., 2012). While present all over the world, it disproportionately affects Africa; 60% of Africans are exposed across their lifetime, and 8% have active infection at any point in time (Howell, Lemoine, & Thursz, 2014). Despite the adoption of the World Health Assembly resolution 63.18 in 2010, which acknowledged HBV as a key global public health problem (Viral hepatitis: WHA 63.18, 2010), care of HBV patients remains fragmented across sub-Saharan Africa (SSA).

Hepatitis B in Rwanda: Closing the gaps to end an epidemic